Loading...

Verrica Pharmaceuticals ($VRCA)

Stock Image

VRCA Overview

Verrica Pharmaceuticals, a clinical stage medical dermatology company, develops and commercializes dermatological treatments in the United States.The company's lead product candidate include VP-102 that is in phase III clinical trial for the treatment of molluscum contagiosum; in phase II clinical trial for the treatment of common warts; and completed phase I clinical trial for the treatment of Genital warts.It is also developing cantharidin-based product candidate, VP-103 for the treatment of plantar warts. The company has a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology indications.Verrica Pharmaceuticals Inc. was founded in 2013 and is headquartered in West Chester, Pennsylvania. (From: StockAnalysis.com)

MORE ABOUT Verrica Pharmaceuticals

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.